Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recent publications published by researchers at the MRC WIMM.

IFITM3 regulates CMV-induced TLR-mediated inflammatory cytokine production by myeloid cells and restricts viral pathogenesis

Conference paper

Clement M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1054 - 1055

IFITM3 rs12252 genotype is associated with IFITM3 expression levels and immune responses

Conference paper

Yin Z. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1070 - 1070

Myeloid cell expression of IRF5 enhances influenza-induced inflammation

Conference paper

Forbester J. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 68 - 68

Viral restriction by IFITM3-is it all down to expression?

Conference paper

Wellington D. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1019 - 1020

IFITM3: How genetics influence influenza infection demographically.

Journal article

Wellington D. et al, (2019), Biomed J, 42, 19 - 26

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.

Journal article

Barker R. et al, (2014), Brain, 137, 1524 - 1532

Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins

Journal article

Barker R. et al, (2013), Journal of Cerebral Blood Flow and Metabolism, 33, 1050 - 1057